oral glp-1 agonist for type 2 diabetes NEW: This new could be a game-changer people with diabetes. Swipe to learn more about orforglipron and visit the link in our bio for the full story New Developments in Pharmacological Treatment

These names may appear on ingredient lists, product labels, or technical documents

If you want a deeper look at the delivery science, All About Liposomes is a helpful place to start

Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)

AHK-Cu can be injected near the scalp for localized follicle stimulation

Meet the Expert: Scott Kipnis, M.D., medical director of bariatric and robotic surgery at Hackensack Meridian Jersey Shore University Medical Center

Glucose-lowering agents and risk of ventricular arrhythmias and sudden cardiac death: a comprehensive review ranging from sulphonylureas to SGLT2 inhibitors